MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Form 8.3 - Willis Towers Watson plc

RNS

RNS Number : 4929C
Citadel Group
19 October 2020
 
























 

Ap 19

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY INFORMATION


























Name of person dealing (Note 1)

Citadel Group

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BDB6Q211

Date of dealing

16 October, 2020

























 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests and short positions (following dealing) in the class of relevant security

    dealt in (Note 3)









Long

Short

ISIN IE00BDB6Q211

Number  (%)

Number  (%)

(1) Relevant securities

264,808 (0.21%)

0 (0.00%)

(2) Derivatives (other than options)

1,638,427 (1.27%)

0 (0.00%)

(3) Options and agreements to purchase/sell

0 (0.00%)

0 (0.00%)

Total

1,903,235 (1.48%)

0 (0.00%)

































Ap 20






























1.  DEALINGS (Note 4)

 

(a)  Purchases and sales




























Purchase/sale

ISIN IE00BDB6Q211

Number of securities

Price per unit (Note 5)

Buy Transaction

89

216.9500 USD

Buy Transaction

1,505

217.1646 USD

Buy Transaction

100

217.5000 USD

Buy Transaction

200

217.5800 USD

Buy Transaction

621

217.7401 USD

Buy Transaction

100

217.8400 USD

Buy Transaction

100

218.0220 USD

Buy Transaction

1

218.0400 USD

Buy Transaction

100

218.0500 USD

Buy Transaction

55

218.0927 USD

Buy Transaction

561

218.0973 USD

Buy Transaction

100

218.1615 USD

Buy Transaction

600

218.2000 USD

Buy Transaction

60

218.2000 USD

Buy Transaction

200

218.2150 USD

Buy Transaction

508

218.4409 USD

Buy Transaction

176

218.8800 USD

Buy Transaction

541

218.9325 USD

Sell Transaction

42

216.7000 USD

Sell Transaction

58

216.7000 USD

Sell Transaction

197

216.7410 USD

Sell Transaction

273

216.7419 USD

Sell Transaction

1,925

216.7600 USD

Sell Transaction

233

216.7897 USD

Sell Transaction

169

216.7901 USD

Sell Transaction

504

216.8208 USD

Sell Transaction

696

216.8208 USD

Sell Transaction

1,555

216.8494 USD

Sell Transaction

1,150

216.8570 USD

Sell Transaction

127

216.8857 USD

Sell Transaction

96

216.8997 USD

Sell Transaction

618

216.9228 USD

Sell Transaction

461

216.9251 USD

Sell Transaction

158

216.9441 USD

Sell Transaction

100

216.9500 USD

Sell Transaction

200

216.9500 USD

Sell Transaction

381

216.9758 USD

Sell Transaction

286

216.9816 USD

Sell Transaction

42

217.0900 USD

Sell Transaction

58

217.0900 USD

Sell Transaction

85

217.1000 USD

Sell Transaction

244

217.1109 USD

Sell Transaction

168

217.1624 USD





















(b)  Derivatives transactions (other than options transactions)























Product name,

e.g. CFD

ISIN IE00BDB6Q211

Nature of transaction

(Note 6)

 

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

























(c)  Options transactions in respect of existing relevant securities

 

(i)  Writing, selling, purchasing or varying























Product name, e.g. call option

Writing, selling, purchasing,

varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type,

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(Note 5)



























(ii)  Exercising
























Product name,

e.g. call option

Number of securities

Exercise price per unit

(Note 5)






























(d)  Other dealings ( including transactions in respect of new securities) (Note 4)




























Nature of transaction

(Note 8)

  Details

  Price per unit

  (if applicable) (Note 5)







 



















Ap 21

















2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
















Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated

None














Is a Supplemental Form 8 attached? (Note 9)


NO

















 Date of disclosure:

19 October, 2020

 Contact name:

Kim Heslop

 Telephone number:

020 7645 9700

If a connected EFM, name of offeree/offeror with which connected

n/a

If a connected EFM, state nature of connection (Note 10)

n/a



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEGPGAWUUPUGUB